QBiotics signs supply, marketing and distribution agreement with Virbac for canine cancer treatment

August, 2018

QBiotics Group has signed an agreement with Virbac, one of the largest dedicated animal health companies globally, to supply, market and distribute its canine anticancer pharmaceutical, tigilanol tiglate. read more